Literature DB >> 21715416

The European Registry on Cushing's syndrome: 2-year experience. Baseline demographic and clinical characteristics.

Elena Valassi1, Alicia Santos, Maria Yaneva, Miklós Tóth, Christian J Strasburger, Philippe Chanson, John A H Wass, Olivier Chabre, Marija Pfeifer, Richard A Feelders, Stylianos Tsagarakis, Peter J Trainer, Holger Franz, Kathrin Zopf, Sabina Zacharieva, Steven W J Lamberts, Antoine Tabarin, Susan M Webb.   

Abstract

OBJECTIVE: The European Registry on Cushing's syndrome (ERCUSYN) is designed to collect prospective and follow-up data at EU level on Cushing's syndrome (CS). DESIGN AND METHODS: Baseline data on 481 CS patients (390 females, 91 males; mean age (±s.d.): 44±14 years) collected from 36 centres in 23 countries, including new patients from 2008 and retrospective cases since 2000. Patients were divided into four major aetiologic groups: pituitary-dependent CS (PIT-CS) (66%), adrenal-dependent CS (ADR-CS) (27%), CS from an ectopic source (ECT-CS) (5%) and CS from other aetiologies (2%).
RESULTS: Proportion of men in the ECT-CS group was higher than in the other groups (P<0.05). The ADR-CS group was older than the PIT-CS (P<0.05). Prevalence of hirsutism (92%) and diabetes (74%) in ECT-CS was higher than in the other groups (P<0.05 and P<0.01 respectively). PIT-CS had more skin alterations, menstrual irregularities and hirsutism than ADR-CS (P<0.01). Reduced libido was more prevalent in men than women (P<0.01). Prevalence of spine osteoporosis was higher in men than women (P<0.05), and males had more vertebral and rib fractures than females (52 vs 18% for vertebrae; P<0.001 and 34 vs 23% for ribs; P<0.05). ECT-CS consulted a diabetologist more frequently than ADR-CS (P<0.05), while a gynaecologist was consulted more often by women with PIT-CS or ADR-CS than with ECT-CS (P<0.05). Overall, weight gain was more common in women than men (P<0.01). CushingQoL and EuroQoL visual analogue scale scores did not differ between the groups.
CONCLUSIONS: The ERCUSYN project demonstrates a heterogeneous clinical presentation of CS at a European level, depending on gender and aetiology.

Entities:  

Mesh:

Year:  2011        PMID: 21715416     DOI: 10.1530/EJE-11-0272

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  89 in total

1.  How to manage pasireotide, when using as medical treatment for Cushing's disease.

Authors:  Stephan Petersenn
Journal:  Endocrine       Date:  2015-09-29       Impact factor: 3.633

Review 2.  Endocrine Tumors Causing Arterial Hypertension: Pathophysiological Mechanisms and Clinical Implications.

Authors:  Agata Buonacera; Benedetta Stancanelli; Lorenzo Malatino
Journal:  High Blood Press Cardiovasc Prev       Date:  2017-04-12

3.  Bone complications in patients with Cushing's syndrome: looking for clinical, biochemical, and genetic determinants.

Authors:  L Trementino; G Appolloni; L Ceccoli; G Marcelli; C Concettoni; M Boscaro; G Arnaldi
Journal:  Osteoporos Int       Date:  2013-10-15       Impact factor: 4.507

4.  Clinical score system in the treatment of Cushing's disease: failure to identify discriminative variables from the German Cushing's Registry.

Authors:  Mareike R Stieg; Matthias K Auer; Christina Berr; Julia Fazel; Martin Reincke; Stephanie Zopp; Alexander Yassouridis; Günter K Stalla
Journal:  Pituitary       Date:  2019-04       Impact factor: 4.107

Review 5.  Normal male sexual function: emphasis on orgasm and ejaculation.

Authors:  Amjad Alwaal; Benjamin N Breyer; Tom F Lue
Journal:  Fertil Steril       Date:  2015-09-16       Impact factor: 7.329

6.  An unusual case of hypercortisolism with multiple weight-bearing bone fractures.

Authors:  Georgios Papadakis; Brigitte Uebelhart; Michel Goumaz; Sophie Zawadynski; Rene Rizzoli
Journal:  Clin Cases Miner Bone Metab       Date:  2013-09

7.  Discovery of Cushing's Syndrome After Bariatric Surgery: Multicenter Series of 16 Patients.

Authors:  Bradley R Javorsky; Ty B Carroll; Nicholas A Tritos; Roberto Salvatori; Anthony P Heaney; Maria Fleseriu; Beverly M K Biller; James W Findling
Journal:  Obes Surg       Date:  2015-12       Impact factor: 4.129

8.  High bone marrow fat in patients with Cushing's syndrome and vertebral fractures.

Authors:  Francesco Ferraù; Salvatore Giovinazzo; Erika Messina; Agostino Tessitore; Sergio Vinci; Gherardo Mazziotti; Andrea Lania; Francesca Granata; Salvatore Cannavò
Journal:  Endocrine       Date:  2019-08-02       Impact factor: 3.633

9.  Mapping CushingQOL scores to EQ-5D utility values using data from the European Registry on Cushing's syndrome (ERCUSYN).

Authors:  X Badia; M Roset; E Valassi; H Franz; A Forsythe; S M Webb
Journal:  Qual Life Res       Date:  2013-03-29       Impact factor: 4.147

10.  A direct comparison of quality of life in obese and Cushing's syndrome patients.

Authors:  Smita Baid Abraham; Brent S Abel; Domenica Rubino; Tonja Nansel; Sheila Ramsey; Lynnette K Nieman
Journal:  Eur J Endocrinol       Date:  2013-04-15       Impact factor: 6.664

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.